Persistent vomiting or diarrhoea can lead to dehydration and acute kidney injury, so seek medical attention if you cannot maintain adequate fluid intake
As the popularity of GLP-1 receptor agonists are being shown to benefit many chronic diseases over and above their effect on weight, John Deanfield, FRCP, FESC, professor of cardiology at the Institute of Cardiovascular Sciences at University College London, told Medical News Today
This higher concentration reduces injection volumes dramatically
The drug could see FDA approval in 2027, according to GoodRx
Dulaglutide : For the management of T2D, dulaglutide is typically initiated at 0.75mg/weekly, with the dose titrated up to 1.5mg/weekly if additional glycemic control is needed
Individuals with prior use of oral antidiabetic drugs or GLP-1 receptor agonists, a history of bariatric surgery, or conditions associated with unintentional weight loss (including malignancy or chronic infection) were excluded